{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T07:15:07Z","timestamp":1724310907800},"reference-count":30,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":566,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Department of Women's and Children's Health, Uppsala University Hospital, Uppsala"},{"name":"Gillbergska foundation, Uppsala"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Paediatr"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1111\/apa.12556","type":"journal-article","created":{"date-parts":[[2014,1,19]],"date-time":"2014-01-19T08:54:47Z","timestamp":1390121687000},"page":"529-536","source":"Crossref","is-referenced-by-count":3,"title":["Children with juvenile idiopathic arthritis frequently experience interruptions to their medical therapy"],"prefix":"10.1111","volume":"103","author":[{"given":"Kalliopi","family":"Kazamia","sequence":"first","affiliation":[{"name":"Department of Women's and Children's Health; Uppsala University; Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Holmquist","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health; Uppsala University; Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Fagerlund","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health; Uppsala University; Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillemor","family":"Berntson","sequence":"additional","affiliation":[{"name":"Department of Women's and Children's Health; Uppsala University; Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,12]]},"reference":[{"key":"10.1111\/apa.12556-BIB0001|apa12556-cit-0001","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/apa.12556-BIB0002|apa12556-cit-0002","first-page":"2275","article-title":"Incidence of juvenile idiopathic arthritis in the Nordic countries a population based study with special reference to the validity of the ILAR and EULAR criteria","volume":"30","author":"Berntson","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/apa.12556-BIB0003|apa12556-cit-0003","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1442-200X.1997.tb03593.x","article-title":"Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan","volume":"39","author":"Fujikawa","year":"1997","journal-title":"Acta Paediatr Jpn"},{"key":"10.1111\/apa.12556-BIB0004|apa12556-cit-0004","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1002\/art.30426","article-title":"Ongoing disease activity and changing categories in a long-term Nordic cohort study of juvenile idiopathic arthritis","volume":"63","author":"Nordal","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0005|apa12556-cit-0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1521-6942(02)90233-0","article-title":"Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis","volume":"16","author":"Oen","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1111\/apa.12556-BIB0006|apa12556-cit-0006","first-page":"72","article-title":"Update on treatment of arthritis in children: new treatments, new goals","volume":"64","author":"Lovell","year":"2006","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1111\/apa.12556-BIB0007|apa12556-cit-0007","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3899\/jrheum.120110","article-title":"Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry","volume":"39","author":"Beukelman","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1111\/apa.12556-BIB0008|apa12556-cit-0008","first-page":"179","article-title":"The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate","volume":"31","author":"Alsufyani","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/apa.12556-BIB0009|apa12556-cit-0009","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1002\/art.20288","article-title":"A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate","volume":"50","author":"Ruperto","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0010|apa12556-cit-0010","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1002\/acr.21697","article-title":"Efficacy and safety of oral and parenteral methotrexate therapy in children with juvenile idiopathic arthritis. An observational study with patients of the German Methotrexate Registry","volume":"64","author":"Klein","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/apa.12556-BIB0011|apa12556-cit-0011","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/art.1780401218","article-title":"The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis","volume":"40","author":"Hashkes","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0012|apa12556-cit-0012","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3899\/jrheum.090482","article-title":"Monitoring methotrexate toxicity in juvenile idiopathic arthritis","volume":"36","author":"Kocharla","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/apa.12556-BIB0013|apa12556-cit-0013","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/art.30367","article-title":"High prevalence of methotrexate intolerance in juvenile idiopathic arthritis: development and validation of a methotrexate intolerance severity score","volume":"63","author":"Bulatovic","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0014|apa12556-cit-0014","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/11532610-000000000-00000","article-title":"Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review","volume":"12","author":"Shenoi","year":"2010","journal-title":"Paediatr Drugs"},{"key":"10.1111\/apa.12556-BIB0015|apa12556-cit-0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/ard.2010.133033","article-title":"Juvenile idiopathic arthritis: state of the art and future perspectives","volume":"69","author":"Martini","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/apa.12556-BIB0016|apa12556-cit-0016","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2431-12-29","article-title":"Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis","volume":"12","author":"Kemper","year":"2012","journal-title":"BMC Pediatr"},{"key":"10.1111\/apa.12556-BIB0017|apa12556-cit-0017","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.23427","article-title":"Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis","volume":"58","author":"Lovell","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0018|apa12556-cit-0018","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/apa.12556-BIB0019|apa12556-cit-0019","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/art.24777","article-title":"Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis","volume":"60","author":"Giannini","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0020|apa12556-cit-0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/apa.12556-BIB0021|apa12556-cit-0021","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"The German etanercept registry for treatment of juvenile idiopathic arthritis","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/apa.12556-BIB0022|apa12556-cit-0022","first-page":"S89","article-title":"Early predictors of outcome in juvenile idiopathic arthritis","volume":"21","author":"Ravelli","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/apa.12556-BIB0023|apa12556-cit-0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/keq308","article-title":"Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients","volume":"50","author":"Southwood","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/apa.12556-BIB0024|apa12556-cit-0024","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/ard.2007.087130","article-title":"Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis","volume":"68","author":"Tynjala","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/apa.12556-BIB0025|apa12556-cit-0025","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/art.21389","article-title":"Patterns of clinical remission in select categories of juvenile idiopathic arthritis","volume":"52","author":"Wallace","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/apa.12556-BIB0026|apa12556-cit-0026","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system","volume":"125","author":"Cox","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/apa.12556-BIB0027|apa12556-cit-0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1546-0096-11-23","article-title":"Mothers\u2019 reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life","volume":"11","author":"Mulligan","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1111\/apa.12556-BIB0028|apa12556-cit-0028","article-title":"Risk of tuberculosis infection in anti-TNF-alpha biological therapy: from bench to bedside","author":"Xie","year":"2013","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1111\/apa.12556-BIB0029|apa12556-cit-0029","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.20128","article-title":"Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry","volume":"62","author":"Smith","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1111\/apa.12556-BIB0030|apa12556-cit-0030","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1542\/peds.90.6.950","article-title":"Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study","volume":"90","author":"Gare","year":"1992","journal-title":"Pediatrics"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapa.12556","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapa.12556","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apa.12556\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T04:48:39Z","timestamp":1648097319000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apa.12556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,12]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1111\/apa.12556","archive":["Portico"],"relation":{},"ISSN":["0803-5253"],"issn-type":[{"value":"0803-5253","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,12]]}}}